NCT06937801

To Assess the Effect of Collagen on Gastrointestinal Discomfort in Healthy Adults With Gastrointestinal Symptoms.

A Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Effect of Collagen Peptide on Perceived Gastrointestinal Discomfort in Healthy Adult Participants With Presence of Gastrointestinal Symptoms

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 116 (actual)
• Sponsor: Rousselot BVBA · Industry
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Accepted

Summary

This study will enroll healthy adults with perceived gastrointestinal symptoms to evaluate the effect of collagen peptides compared to placebo.

Detailed description

This double-blind, placebo-controlled trial aims to assess the efficacy of collagen peptides in addressing gastrointestinal discomfort, gut microbiota composition, gut permeability, mood, anxiety, perceived stress, quality of life and cognitive function. The study will include healthy adults experiencing gastrointestinal symptoms while excluding individuals with chronic illnesses or recent infections that might impact the results.

Conditions

• Gastrointestinal Disorders

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Collagen Peptide	10g Collagen Hydrolysate per sachet
OTHER	Placebo	Placebo - active ingredients: N/A

Timeline

• Start date: 2025-05-08
• Primary completion: 2025-11-21
• Completion: 2025-11-21
• First posted: 2025-04-22
• Last updated: 2025-11-26

Locations

1 site across 1 country: Canada